Inhibikase Therapeutics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Inhibikase Therapeutics Inc 公司

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).

Inhibikase Therapeutics Inc简介



公司代码IKT

公司名称Inhibikase Therapeutics Inc

上市日期Dec 23, 2020

CEOIwicki (Mark T)

员工数量15

证券类型Ordinary Share

年结日Dec 23

公司地址1000 N. West Street, Suite 1200

城市WILMINGTON

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编19801

电话13022953800

网址https://www.inhibikase.com/

公司代码IKT

上市日期Dec 23, 2020

CEOIwicki (Mark T)

Inhibikase Therapeutics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Roberto Bellini

Independent Director

1.46M

--

Mr. Vincent E. (Vince) Aurentz

Independent Director

893.54K

--

Mr. Amit D. Munshi

Independent Chairman of the Board

431.81K

--

Mr. Arvind Kush

Independent Director

145.00K

--

Dr. Roy Freeman, M.D.

Independent Director

--

Mr. Dennis N. Berman

Independent Director

--

Mr. David Canner, Ph.D.

Independent Director

--

Mr. Mike Moyer

Managing Director of LifeSci Advisors

--

Mr. Mark T. Iwicki

Chief Executive Officer, Director

--

Dr. Christopher H. (Chris) Cabell, M.D.

President, Head - Research and Development

--

名称

名称/职务

职务

持股

持股变动

Mr. Roberto Bellini

Independent Director

1.46M

--

Mr. Vincent E. (Vince) Aurentz

Independent Director

893.54K

--

Mr. Amit D. Munshi

Independent Chairman of the Board

431.81K

--

Mr. Arvind Kush

Independent Director

145.00K

--

Dr. Roy Freeman, M.D.

Independent Director

--

Mr. Dennis N. Berman

Independent Director

--

收入明细

由于公司未披露，未能获取相关数据

由于公司未披露，未能获取相关数据

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 1月10日周六

持股股东

股东类型

持股股东

占比

Sands Capital Ventures LLC

10.77%

Soleus Capital Management, L.P.

5.23%

Trails Edge Capital Partners LP

5.08%

Fairmount Funds Management LLC

5.07%

SP IKT Holdings LLC

4.83%

其他

69.02%

持股股东

占比

Sands Capital Ventures LLC

10.77%

Soleus Capital Management, L.P.

5.23%

Trails Edge Capital Partners LP

5.08%

Fairmount Funds Management LLC

5.07%

SP IKT Holdings LLC

4.83%

其他

69.02%

股东类型

持股股东

占比

Hedge Fund

31.76%

Investment Advisor

11.96%

Investment Advisor/Hedge Fund

4.85%

Corporation

4.83%

Private Equity

4.48%

Individual Investor

3.18%

Research Firm

0.24%

Bank and Trust

0.06%

Pension Fund

0.04%

其他

38.60%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

122

64.55M

53.39%

+6.52M

2025Q3

110

54.77M

73.50%

+878.44K

2025Q2

87

62.36M

83.88%

+6.72M

2025Q1

82

60.21M

81.40%

+7.53M

2024Q4

61

58.78M

83.36%

+15.59M

2024Q3

38

1.99M

24.34%

-203.16K

2024Q2

42

2.13M

28.26%

+379.22K

2024Q1

47

1.51M

21.65%

-625.47K

2023Q4

49

1.53M

25.68%

-638.36K

2023Q3

54

2.02M

35.52%

-749.23K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Sands Capital Ventures LLC

13.02M

10.77%

+2.07M

+18.89%

Nov 21, 2025

Soleus Capital Management, L.P.

6.33M

5.23%

--

Sep 30, 2025

Fairmount Funds Management LLC

6.13M

5.07%

--

Sep 30, 2025

SP IKT Holdings LLC

5.84M

4.83%

+5.84M

--

Oct 21, 2024

Perceptive Advisors LLC

5.42M

4.48%

-10.72K

-0.20%

Sep 30, 2025

Commodore Capital LP

5.40M

4.46%

--

Sep 30, 2025

Adar1 Capital Management LLC

5.25M

4.34%

+125.50K

+2.45%

Sep 30, 2025

The Vanguard Group, Inc.

3.27M

2.71%

+48.97K

+1.52%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.75M

2.27%

+323.60K

+13.34%

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

iShares Micro-Cap ETF

0.02%

iShares Russell 2000 Value ETF

0.01%

ProShares Hedge Replication ETF

0%

iShares Russell 2000 ETF

0%

iShares Russell 2000 Growth ETF

0%

Global X Russell 2000 ETF

0%

Proshares Ultra Russell 2000

0%

ProShares UltraPro Russell2000

0%

iShares Micro-Cap ETF

占比0.02%

iShares Russell 2000 Value ETF

占比0.01%

ProShares Hedge Replication ETF

占比0%

iShares Russell 2000 ETF

占比0%

iShares Russell 2000 Growth ETF

占比0%

Global X Russell 2000 ETF

占比0%

Proshares Ultra Russell 2000

占比0%

ProShares UltraPro Russell2000

占比0%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

Jun 29, 2023

Merger

6→1

Jun 29, 2023

Merger

6→1

Jun 29, 2023

Merger

6→1

Jun 29, 2023

Merger

6→1

公告日期

除权除息日

类型

比率

Jun 29, 2023

Merger

6→1

Jun 29, 2023

Merger

6→1

Jun 29, 2023

Merger

6→1

Jun 29, 2023

Merger

6→1